M Cordero-Coma

Summary

Publications

  1. doi request reprint Anti-tumor necrosis factor-α therapy in uveitis
    Miguel Cordero-Coma
    Head of the Uveitis Unit, Department of Ophthalmology, University Hospital of León, Leon, Spain Instituto Biomedicina IBIOMED, University of Leon, Leon, Spain Electronic address
    Surv Ophthalmol 60:575-89. 2015
  2. doi request reprint Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues
    Miguel Cordero-Coma
    a 1 University of León, Instituto Biomedicina IBIOMED, University Hospital of León, Leon, Spain 34 654403609 34 987 233322
    Expert Opin Drug Saf 14:1353-71. 2015
  3. doi request reprint Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues
    Miguel Cordero-Coma
    Uveitis Unit, Department of Ophthalmology, University Hospital of León, Leon, Spain 34 654403609 34 987 233322
    Expert Opin Drug Saf 14:1071-86. 2015
  4. doi request reprint Drug-induced uveitis
    Miguel Cordero-Coma
    Department of Ophthalmology, University Hospital of León, Leon, Spain 34 987237400 34 987233322
    Expert Opin Drug Saf 14:111-26. 2015
  5. doi request reprint Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis
    Miguel Cordero-Coma
    Department of Ophthalmology, University Hospital of León, Leon, Spain Uveitis Unit, University Hospital of León, Leon, Spain Electronic address
    J AAPOS 17:632-4. 2013
  6. doi request reprint [Treatment of presumed tuberculous uveitis affecting the posterior segment: diagnostic confirmation and long term outcomes]
    M Cordero-Coma
    Servicio de Oftalmologia, Complejo Asistencial Universitario de León, Leon, Espana
    Arch Soc Esp Oftalmol 88:339-44. 2013
  7. pmc Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
    Maria Carmen Cénit
    Instituto de Parasitologia y Biomedicina Lopez Neyra, IPBLN, CSIC, Parque Tecnologico Ciencias de la Salud, Avenida del Conocimiento, 18100 Armilla, Granada, Spain
    BMC Med Genet 14:52. 2013
  8. doi request reprint Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis
    Miguel Cordero-Coma
    Department of Ophthalmology, Hospital Universitario de León, Leon, Spain
    Ocul Immunol Inflamm 21:19-27. 2013
  9. doi request reprint Refractory pyoderma gangrenosum of the orbit and the lacrimal sac
    Miguel Cordero-Coma
    Department of Ophthalmology, Hospital Universitario de León, Leon, Spain
    Orbit 31:249-51. 2012
  10. doi request reprint Adjunctive globe magnetic resonance imaging in the diagnosis of posterior scleritis
    Miguel Cordero-Coma
    Uveitis Unit, Hospital Universitario de León, Spain
    Can J Ophthalmol 46:329-32. 2011

Collaborators

  • Taygan Yilmaz
  • Sumru Onal
  • Maria Carmen Cénit
  • S Calleja
  • I del Barrio-Manso
  • Ricardo Blanco
  • José Manuel Martín-Villa
  • David Diaz Valle
  • Enrique de Ramon
  • Manuel Diaz-Llopis
  • Ana Marquez
  • Norberto Ortego-Centeno
  • Javier Martin
  • Agustin Martinez-Berriotxoa
  • Víctor Llorenç
  • José Luis García Serrano
  • Alejandro Fonollosa
  • Joaquín Cañal
  • María José Del Río
  • Alfredo Adan
  • Marina Begoña Gorroño-Echebarría
  • E Rodriguez
  • J G Ruiz de Morales
  • M Llorente
  • M Franco
  • L Tuñón
  • A Toribio-García
  • E Baragaño

Detail Information

Publications16

  1. doi request reprint Anti-tumor necrosis factor-α therapy in uveitis
    Miguel Cordero-Coma
    Head of the Uveitis Unit, Department of Ophthalmology, University Hospital of León, Leon, Spain Instituto Biomedicina IBIOMED, University of Leon, Leon, Spain Electronic address
    Surv Ophthalmol 60:575-89. 2015
    ..We also present a summary of the science behind the use of anti-TNF-α agents in ocular inflammation and the evidence for their efficacy. ..
  2. doi request reprint Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues
    Miguel Cordero-Coma
    a 1 University of León, Instituto Biomedicina IBIOMED, University Hospital of León, Leon, Spain 34 654403609 34 987 233322
    Expert Opin Drug Saf 14:1353-71. 2015
    ..Chronic viral and mycobacterial infections in the setting of non-infectious uveitis create a number of diagnostic but also therapeutic dilemmas to clinicians because they can be exacerbated by IS therapies with detrimental effects...
  3. doi request reprint Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues
    Miguel Cordero-Coma
    Uveitis Unit, Department of Ophthalmology, University Hospital of León, Leon, Spain 34 654403609 34 987 233322
    Expert Opin Drug Saf 14:1071-86. 2015
    ..Therapeutic decision-making and management may be of particular difficulty in pregnancy as well as in patients with associated malignancies unrelated to a specific ophthalmic inflammatory condition...
  4. doi request reprint Drug-induced uveitis
    Miguel Cordero-Coma
    Department of Ophthalmology, University Hospital of León, Leon, Spain 34 987237400 34 987233322
    Expert Opin Drug Saf 14:111-26. 2015
    ..There are an increasing number of medications that have been related to the onset of intraocular inflammation. Identification of these inciting agents may decisively help the diagnostic algorithm involving new cases of uveitis...
  5. doi request reprint Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis
    Miguel Cordero-Coma
    Department of Ophthalmology, University Hospital of León, Leon, Spain Uveitis Unit, University Hospital of León, Leon, Spain Electronic address
    J AAPOS 17:632-4. 2013
    ..During 10 months' follow-up, his uveitis remained quiet. To our knowledge this is the first report using an intravitreal sustained-release dexamethasone implant as a perioperative anti-inflammatory medication. ..
  6. doi request reprint [Treatment of presumed tuberculous uveitis affecting the posterior segment: diagnostic confirmation and long term outcomes]
    M Cordero-Coma
    Servicio de Oftalmologia, Complejo Asistencial Universitario de León, Leon, Espana
    Arch Soc Esp Oftalmol 88:339-44. 2013
    ..To determine the level of agreement with the presumed diagnosis and long term clinical outcomes after antituberculous therapy (ATT) in a group of patients with presumed tuberculous uveitis (PTU) affecting the posterior segment...
  7. pmc Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
    Maria Carmen Cénit
    Instituto de Parasitologia y Biomedicina Lopez Neyra, IPBLN, CSIC, Parque Tecnologico Ciencias de la Salud, Avenida del Conocimiento, 18100 Armilla, Granada, Spain
    BMC Med Genet 14:52. 2013
    ..We aimed to investigate for the first time the potential influence of the IL2/IL21, IL2RA and IL2RB most associated polymorphisms with autoimmunity on the endogenous non-anterior uveitis genetic predisposition...
  8. doi request reprint Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis
    Miguel Cordero-Coma
    Department of Ophthalmology, Hospital Universitario de León, Leon, Spain
    Ocul Immunol Inflamm 21:19-27. 2013
    ..To establish evidence-based recommendations regarding the use of anti-Tumor Necrosis Factor alpha (TNF-α) agents for managing uveitis patients...
  9. doi request reprint Refractory pyoderma gangrenosum of the orbit and the lacrimal sac
    Miguel Cordero-Coma
    Department of Ophthalmology, Hospital Universitario de León, Leon, Spain
    Orbit 31:249-51. 2012
    ..It rarely affects the eye, orbit, and/or ocular adnexa. We describe one case of PG affecting both orbits and the lacrimal sac in a patient with Crohn's disease...
  10. doi request reprint Adjunctive globe magnetic resonance imaging in the diagnosis of posterior scleritis
    Miguel Cordero-Coma
    Uveitis Unit, Hospital Universitario de León, Spain
    Can J Ophthalmol 46:329-32. 2011
    ..To report 4 cases of posterior scleritis with unusually unremarkable ultrasonography findings in which diagnosis was based on magnetic resonance imaging (MRI) examination...
  11. doi request reprint [Toxoplasmic retinochoroiditis: relapse vs choroidal neovascular membrane]
    M Cordero-Coma
    Servicio de Oftalmologia, Hospital de Leon, Espana
    Arch Soc Esp Oftalmol 85:410-3. 2010
    ....
  12. ncbi request reprint [Successful treatment of surgically induced necrotizing sclerokeratitis (SINS) with systemic immunosuppresive agents and amniotic membrane grafting]
    M Cordero-Coma
    Hospital de León C Altos de Nava, s n 24080 León, Espana
    Arch Soc Esp Oftalmol 84:577-80. 2009
    ..She had no previous history of systemic autoimmune disease. Histopathology of the lesion revealed necrotic granulomatosis with an increased number of plasma cells...
  13. doi request reprint The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitis revisited: utility of the new IGRAs
    M Cordero-Coma
    Uveitis Unit, Hospital de León SACYL, Leon, Spain
    Eye (Lond) 24:36-43. 2010
    ..To explore the utility of a specific immune response to Mycobacterium tuberculosis in a population of immunosuppressed idiopathic chronic posterior uveitis patients, by means of a tuberculosis-specific interferon-gamma release assay...
  14. pmc Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study
    S Calleja
    Department of Clinical Immunology, Complejo Hospitalario Universitario de León, Leon, Spain
    Eye (Lond) 26:468-77. 2012
    ..To explore immunoregulatory and anti-inflammatory pathways specifically targeted by a subcutaneous anti-TNFαdrug-adalimumab-which might be relevant for controlling refractory uveitis...
  15. doi request reprint [Creutzfeldt - Jakob presenting with isolated visual symptoms: the Heidenhain variant]
    I del Barrio-Manso
    Servicio de Oftalmologia, Hospital de Infanta Cristina, Parla, Madrid, Espana
    Arch Soc Esp Oftalmol 85:341-4. 2010
    ..Her past medical history was unremarkable. She died less than three months after the onset...